This viva refers to Section A(ii) of the 2017 CICM Primary Syllabus. Section A(ii) mentions that the exam candidates are expected to "describe the pharmaceutics and formulation of drugs", which includes drug excipients.
An excipient is "A relatively inert substance which functions to ensure the dosage, stability and bioavailability of the active agent"
Examples of adverse effects associated with specific classes include the following examples:
Kalasz, Huba, and Istvan Antal. "Drug excipients." Current medicinal chemistry 13.21 (2006): 2535-2563.
Nema, Sandeep, R. J. Washkuhn, and R. J. Brendel. "Excipients and their use in injectable products." PDA Journal of Pharmaceutical Science and Technology 51.4 (1997): 166-171.
Pifferi, Giorgio, and Patrizia Restani. "The safety of pharmaceutical excipients." Il Farmaco 58.8 (2003): 541-550.
Crowley, Patrick, and Luigi G. Martini. "Drug-excipient interactions." Pharm Technol 4 (2001): 7-12.
Golightly, Larry K., Susan S. Snmiinskc, and L. Bennett A'Iiclzacl. "Pharmaceutical Excipients Adverse Effects Associated with Inactive Ingredients in." Medical Toxicology 3 (1988): 128-165.
Schep, Leo J., et al. "Diethylene glycol poisoning." Clinical toxicology 47.6 (2009): 525-535.